| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 29.12▼ | 28.92▲ | 29.00▲ | 28.11▲ | 28.31▲ |
| MA10 | 29.05▲ | 28.95▲ | 29.07▲ | 28.33▲ | 27.88▲ |
| MA20 | 29.01▲ | 29.02▲ | 28.57▲ | 28.41▲ | 30.90▼ |
| MA50 | 29.06▲ | 28.07▲ | 28.25▲ | 28.00▲ | 25.20▲ |
| MA100 | 28.85▲ | 28.23▲ | 28.27▲ | 30.95▼ | 19.88▲ |
| MA200 | 27.95▲ | 28.30▲ | 28.67▲ | 27.10▲ | 17.47▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.015▲ | -0.058▼ | 0.021▲ | 0.063▲ | -0.632▼ |
| RSI | 51.656▲ | 54.880▲ | 56.927▲ | 52.907▲ | 51.939▲ |
| STOCH | 76.882 | 49.363 | 46.206 | 45.305 | 53.586 |
| WILL %R | -37.097 | -41.304 | -59.459 | -30.298 | -56.722 |
| CCI | 54.310 | 36.418 | -7.766 | 82.624 | -18.012 |
|
Thursday, March 19, 2026 03:00 PM
Successfully licensed helicase-primase inhibitor program for recurrent genital herpes to Gilead, including candidates ABI-5366 and ABI-1179, ...
|
|
Tuesday, December 23, 2025 07:45 AM
Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...
|
|
Monday, December 22, 2025 05:19 AM
(RTTNews) - Gilead Sciences (GILD) and Assembly Biosciences (ASMB) announced Gilead has exercised its combined option to exclusively license Assembly Bio's herpes simplex virus helicase-primase ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 28.40 | 29.7499 | 28.40 | 29.01 | 37,844 |
| 01/04/26 | 28.05 | 29.92 | 28.05 | 29.43 | 77,545 |
| 31/03/26 | 27.01 | 28.135 | 26.655 | 27.75 | 97,548 |
| 30/03/26 | 27.84 | 28.115 | 26.3183 | 26.64 | 72,272 |
| 27/03/26 | 28.63 | 28.89 | 27.25 | 27.70 | 70,112 |
| 26/03/26 | 28.65 | 29.49 | 28.49 | 28.87 | 65,003 |
| 25/03/26 | 28.45 | 29.50 | 28.40 | 28.67 | 58,400 |
| 24/03/26 | 28.10 | 28.45 | 27.585 | 28.23 | 70,178 |
| 23/03/26 | 29.10 | 30.18 | 27.53 | 28.58 | 97,918 |
| 20/03/26 | 30.13 | 30.13 | 27.69 | 28.46 | 82,799 |
|
|
||||
|
|
||||
|
|